X. Gamé

5.2k total citations · 1 hit paper
264 papers, 3.3k citations indexed

About

X. Gamé is a scholar working on Urology, Rheumatology and Surgery. According to data from OpenAlex, X. Gamé has authored 264 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 143 papers in Urology, 111 papers in Rheumatology and 81 papers in Surgery. Recurrent topics in X. Gamé's work include Urinary Bladder and Prostate Research (111 papers), Pelvic floor disorders treatments (103 papers) and Urological Disorders and Treatments (48 papers). X. Gamé is often cited by papers focused on Urinary Bladder and Prostate Research (111 papers), Pelvic floor disorders treatments (103 papers) and Urological Disorders and Treatments (48 papers). X. Gamé collaborates with scholars based in France, United Kingdom and United States. X. Gamé's co-authors include P. Rischmann, Bernard Malavaud, G. Amarenco, P. Denys, B. Peyronnet, É. Castel-Lacanal, A. Ruffion, J. Guillotreau, Marc Mouzin and Emmanuel Chartier‐Kastler and has published in prestigious journals such as The Journal of Urology, American Journal Of Pathology and European Urology.

In The Last Decade

X. Gamé

234 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Comprehensive Review of Overactive Bladder Pathophysiology: On the Way to Tailored Treatment

2019 249 citations B. Peyronnet, G. Amarenco et al. European Urology profile →

Peers

Countries citing papers authored by X. Gamé

Since Specialization

Citations

This map shows the geographic impact of X. Gamé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by X. Gamé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites X. Gamé more than expected).

Fields of papers citing papers by X. Gamé

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by X. Gamé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by X. Gamé. The network helps show where X. Gamé may publish in the future.

Co-authorship network of co-authors of X. Gamé

This figure shows the co-authorship network connecting the top 25 collaborators of X. Gamé. A scholar is included among the top collaborators of X. Gamé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with X. Gamé. X. Gamé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	French translation of the Peyronie's disease questionnaire: A pilot study 2024 ·PubMed ·(unknown), L. Ferretti, (unknown), (unknown), (unknown), M. Roumiguié, X. Gamé, (unknown), É. Huyghe	1
2	Potential benefits of neoadjuvant radiotherapy prior to “en bloc” compartmental resection of pure retroperitoneal liposarcomas 2024 ·World Journal of Urology ·(unknown), (unknown), Laurent Ghouti, Anne Ducassou, (unknown), (unknown), M. Roumiguié, X. Gamé, (unknown), M. Thoulouzan, (unknown)	1
3	How to define failure of intradetrusor injections of botulinum toxin A for neurogenic detrusor overactivity 2024 ·Neurourology and Urodynamics ·(unknown), B. Peyronnet, Marianne de Sèze, A. Even, (unknown), G. Amarenco, Emmanuel Chartier‐Kastler, L. Le Normand, A. Manunta, G. Karsenty, J. Kerdraon, A. Ruffion, C. Saussine, F. Le Breton, (unknown), É. Castel-Lacanal, P. Denys, V. Phé, X. Gamé	2
4	Significant prostate cancer risk after MRI-guided biopsy showing benign findings: Results from a cohort of 381 men 2023 ·PubMed ·(unknown), Sarah Péricart, (unknown), R. Aziza, D. Portalez, (unknown), M. Soulié, X. Gamé, Bernard Malavaud, M. Thoulouzan, N. Doumerc, Thomas Prudhomme, Guillaume Ploussard, M. Roumiguié	0
5	Neuromodulation sacrée pour trouble de la vidange vésicale : expérience d’un centre universitaire français 2023 ·Progrès en Urologie ·(unknown), (unknown), (unknown), M. Soulié, É. Castel-Lacanal, X. Gamé	0
6	Hypertrophie bénigne de la prostate : une communauté digitale pour identifier les attentes des patients 2023 ·Laurent Bardin, (unknown), R. Mallet, A. Faix, (unknown), (unknown), Xavier Rébillard, (unknown), X. Gamé	1
7	Unilateral versus bilateral sacral neuromodulation test in the treatment of refractory idiopathic overactive bladder: A randomized controlled pilot trial 2020 ·Neurourology and Urodynamics ·Laurent Wagner, Sandrine Alonso, L. Le Normand, A. Faix, (unknown), Christel Castelli, X. Gamé, Jean‐Nicolas Cornu, É. Bey	8
8	Long‐term outcomes of artificial urinary sphincter in female patients with spina bifida 2020 ·Neurourology and Urodynamics ·(unknown), Marie‐Aimée Perrouin‐Verbe, J. Hascoët, É. Bey, (unknown), (unknown), B. Perrouin-Verbe, X. Gamé, A. Manunta, (unknown), G. Capon, B. Peyronnet	5
9	Cellular Senescence in Renal and Urinary Tract Disorders 2020 ·Cells ·Yohan Santin, Philippe Lluel, P. Rischmann, X. Gamé, Jeanne Mialet‐Perez, Angelo Parini	9
10	Widespread Postponement of Functional Urology Cases During the COVID-19 Pandemic: Rationale, Potential Pitfalls, and Future Consequences 2020 ·European Urology ·V. Phé, G. Karsenty, G. Robert, X. Gamé, Jean‐Nicolas Cornu	13
11	Urologic Disorders are Still the Leading Cause of In-hospital Death in Patients With Spina Bifida 2019 ·Urology ·B. Peyronnet, Fei Gao, Charlène Brochard, Emmanuel Oger, Lucie‐Marie Scailteux, Frédéric Balusson, J. Hascoët, (unknown), Z. Khene, Sahar Bayat, (unknown), (unknown), (unknown), J. Kerdraon, Guillaume Bouguen, X. Gamé, Laurent Siproudhis, A. Manunta	15
12	Benign Prostatic Hyperplasia Endoscopic Surgical Procedures in Kidney Transplant Recipients: A Comparison Between Holmium Laser Enucleation of the Prostate, GreenLight Photoselective Vaporization of the Prostate, and Transurethral Resection of the Prostate 2019 ·Journal of Endourology ·Thomas Prudhomme, (unknown), Morgane Péré, (unknown), C. Michiels, F. Sallusto, J. Rigaud, Pascal Glémain, Nassim Kamar, Gilles Blancho, M. Soulié, P. Rischmann, Georges Karam, X. Gamé, G. Robert, Julien Branchereau	7
13	Perception of intermittent self-catheterization by urologists: preliminary results of a survey among the French Association of Urology 2018 ·Neurourology and Urodynamics ·François Hervé, V. Phé, R. Mallet, X. Gamé, Karel Everaert	1
14	Reliability of urinary cytology and cystoscopy for the screening and diagnosis of bladder cancer in patients with neurogenic bladder: A systematic review 2017 ·Neurourology and Urodynamics ·(unknown), J. Hascoët, A. Manunta, Solène‐Florence Kammerer‐Jacquet, G. Verhoest, Charlène Brochard, L. Freton, J. Kerdraon, (unknown), Laurent Siproudhis, (unknown), Benjamin M. Brucker, X. Gamé, B. Peyronnet	10
15	Outcomes of intra-detrusor injections of botulinum toxin in patients with spina bifida: a systematic review 2016 ·J. Hascoët, A. Manunta, Charlène Brochard, Alexis Arnaud, J. Kerdraon, (unknown), I. Bonan, B. Frémond, Laurent Siproudhis, X. Gamé, B. Peyronnet	2
16	Prospective Study of Methods of Renal Function Evaluation in Patients With Neurogenic Bladder Dysfunction 2013 ·Urology ·(unknown), Emmanuel Villar, Julien Allard, É. Castel-Lacanal, J. Guillotreau, Bernard Malavaud, P. Rischmann, Ivan Tack, A. Ruffion, X. Gamé	13
17	Botulinum toxin type A injections in the augmented bladder after failure of augmentation enterocystoplasty in neurological patients: A retrospective multicenter study 2013 ·Annals of Physical and Rehabilitation Medicine ·(unknown), (unknown), G. Karsenty, A. Ruffion, (unknown), V. Forin, X. Gamé, (unknown), A. Manunta, (unknown), P. Grise	0
18	Évaluation « coût conséquence » d’une nouvelle approche thérapeutique par la toxine botulinique pour la prise en charge des patients neurologiques présentant une hyperactivité du détrusor 2009 ·Journal de Pharmacie Clinique ·(unknown), A. Ruffion, P. Denys, X. Gamé, G. Amarenco, M. De Sèze, F. Haab, G. Karsenty, J. Kerdraon, B. Perrouin-Verbe, J.-M. Soler, C. Saussine, Emmanuel Chartier‐Kastler, G. Aulagner	1
19	Radical Cystectomy for Bladder Cancer: Morbidity of Laparoscopic Versus Open Surgery 2008 ·The Journal of Urology ·J. Guillotreau, X. Gamé, Marc Mouzin, N. Doumerc, R. Mallet, F. Sallusto, Bernard Malavaud, P. Rischmann	61
20	Botulinum Toxin A (Botox®) Intradetrusor Injections in Adults with Neurogenic Detrusor Overactivity/Neurogenic Overactive Bladder: A Systematic Literature Review 2007 ·European Urology ·G. Karsenty, P. Denys, G. Amarenco, Marianne de Sèze, X. Gamé, François Haab, J. Kerdraon, B. Perrouin-Verbe, A. Ruffion, C. Saussine, J.-M. Soler, Brigitte Schurch, Emmanuel Chartier‐Kastler	247

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact